Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Other Accumulated Expenses (2020 - 2022)

Rapid Micro Biosystems (RPID) has disclosed Other Accumulated Expenses for 3 consecutive years, with $200000.0 as the latest value for Q2 2022.

  • Quarterly Other Accumulated Expenses fell 63.1% to $200000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $200000.0 through Jun 2022, down 63.1% year-over-year, with the annual reading at $338000.0 for FY2021, 199.12% up from the prior year.
  • Other Accumulated Expenses hit $200000.0 in Q2 2022 for Rapid Micro Biosystems, up from $86000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $694000.0 in Q3 2021 to a low of $86000.0 in Q1 2022.
  • Historically, Other Accumulated Expenses has averaged $328833.3 across 3 years, with a median of $269000.0 in 2021.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 199.12% in 2021 and later plummeted 63.1% in 2022.
  • Year by year, Other Accumulated Expenses stood at $113000.0 in 2020, then skyrocketed by 199.12% to $338000.0 in 2021, then plummeted by 40.83% to $200000.0 in 2022.
  • Business Quant data shows Other Accumulated Expenses for RPID at $200000.0 in Q2 2022, $86000.0 in Q1 2022, and $338000.0 in Q4 2021.